TARSUS PHARMACEUTICALS INC (TARS)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for TARS
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| TARS | Director | 80 | [] | [] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| RXST | Director | 80 | [] | [] | 2026 |
| EW | Managing Director and Co-Founder Versant Ventures | 73 | ["Managing Director and Co-Founder Versant Ventures", "Managing Director and Co-Founder of Versant Ventures", "General Partner at Brentwood Venture Capital", "Founder, Chairman, and CEO of Chiron Vision", "Founder and President of Advanced Medical Optics, Inc.", "Former assistant professor in the Department of Surgery at the Indiana University School of Medicine"] | ["AuditCommittee*", "Compensation and Governance Committee", "Audit and Nominating and Corporate Governance Committees", "Compensation Committee", "Compensation, Nominating and Governance Committee"] | 2020 |
| GKOS | Chairman of the Board | 72 | ["Proven record of building and operating large, successful medical product companies","Extensive knowledge of medical devices and drug delivery, particularly in ophthalmology","More than 23 years in general management in the healthcare industry","Experience as a managing director and co-founder of Versant Ventures Management LLC","Prior experience on the boards of U.S. public companies"] | [] | 2018 |
| EYE | Director | 62 | ["Co-founder of Versant Ventures","General partner at Brentwood Venture Capital","Chairman and Chief Executive Officer of Chiron Vision","Founder and President of American Medical Optics","Assistant professor in the Department of Surgery at Indiana University School of Medicine"] | ["Audit and Finance","Science and Technology","Organization, Compensation and Corporate Governance"] | 2008 |
Biography sourced from the proxy statement filing.
William J. Link, Ph.D. has served as a member of our Board of Directors since January 2017. Dr. Link is a managing director and co-founder of both Flying L Partners, a venture capital firm formed in 2016 to focus on investing primarily in the ophthalmic space, and Versant Venture Management LLC (Versant), a life science venture capital firm investing in early stage healthcare companies. Dr. Link has also served as the Chairperson of the board of directors of Lensar Inc. since November 2017 and RxSight, Inc. since November 2016. Prior to co-founding Versant in 1999, Dr. Link was a general partner at Brentwood Venture Capital. From 1987 to 1997, Dr. Link was founder, chairman, and Chief Executive Officer of Chiron Vision Corporation (acquired by Bausch & Lomb Surgical, Inc.). He also founded and served as President of American Medical Optics (acquired by Allergan). Dr. Link served as a director of Advanced Medical Optics (acquired by Abbott Laboratories) from 2002 to 2009 and Inogen, Inc. from 2003 to February 2014. Before entering the healthcare industry, Dr. Link was an assistant professor in the Department of Surgery at the Indiana University School of Medicine. He has been a member of the boards of directors of Edwards Lifesciences Corporation from May 2009 to May 2021, Second Sight Medical Products, Inc. from 2003 to May 2020, Glaukos Corporation from June 2001 to December 2021, and Oyster Point Pharma, Inc. from July 2015 to March 2022. Dr. Link is also a member of the board of directors of several private companies. Dr. Link holds a B.S., an M.S., and a Ph.D. in mechanical engineering from Purdue University. We believe Dr. Link is qualified to serve on our Board of Directors because of his extensive experience in successfully commercializing products in the medical device industry, as well as his prior experience on the boards of U.S. public companies.